Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease.

Wandersee NJ, Maciaszek JL, Giger KM, Hanson MS, Zheng S, Guo Y, Mickelson B, Hillery CA, Lykotrafitis G, Low PS, Hogg N.

Blood Cells Mol Dis. 2015 Feb;54(2):183-8. doi: 10.1016/j.bcmd.2014.11.004. Epub 2014 Nov 25.

2.

Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation.

Xu H, Wandersee NJ, Guo Y, Jones DW, Holzhauer SL, Hanson MS, Machogu E, Brousseau DC, Hogg N, Densmore JC, Kaul S, Hillery CA, Pritchard KA Jr.

Blood. 2014 Dec 18;124(26):3978-81. doi: 10.1182/blood-2014-04-560813. Epub 2014 Oct 22.

3.

Donor Pretreatment With IL-1 Receptor Antagonist Attenuates Inflammation and Improves Functional Potency in Islets From Brain-Dead Nonhuman Primates.

Danobeitia JS, Hanson MS, Chlebeck P, Park E, Sperger JM, Schwarznau A, Fernandez LA.

Cell Transplant. 2015;24(9):1863-77. doi: 10.3727/096368914X681045. Epub 2014 Apr 22.

4.

A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.

Hanson MS, Xu H, Flewelen TC, Holzhauer SL, Retherford D, Jones DW, Frei AC, Pritchard KA Jr, Hillery CA, Hogg N, Wandersee NJ.

Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H328-36. doi: 10.1152/ajpheart.00500.2012. Epub 2012 Nov 2.

5.

Standardized transportation of human islets: an islet cell resource center study of more than 2,000 shipments.

Kaddis JS, Hanson MS, Cravens J, Qian D, Olack B, Antler M, Papas KK, Iglesias I, Barbaro B, Fernandez L, Powers AC, Niland JC.

Cell Transplant. 2013;22(7):1101-11. doi: 10.3727/096368912X653219. Epub 2012 Aug 10.

6.

Early activation of the inflammatory response in the liver of brain-dead non-human primates.

Danobeitia JS, Sperger JM, Hanson MS, Park EE, Chlebeck PJ, Roenneburg DA, Sears ML, Connor JX, Schwarznau A, Fernandez LA.

J Surg Res. 2012 Aug;176(2):639-48. doi: 10.1016/j.jss.2011.10.042. Epub 2011 Nov 19.

PMID:
22440934
7.

Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction.

Hanson MS, Piknova B, Keszler A, Diers AR, Wang X, Gladwin MT, Hillery CA, Hogg N.

Br J Haematol. 2011 Aug;154(4):502-11. doi: 10.1111/j.1365-2141.2011.08738.x. Epub 2011 May 20.

8.

Differences between human and rodent pancreatic islets: low pyruvate carboxylase, atp citrate lyase, and pyruvate carboxylation and high glucose-stimulated acetoacetate in human pancreatic islets.

MacDonald MJ, Longacre MJ, Stoker SW, Kendrick M, Thonpho A, Brown LJ, Hasan NM, Jitrapakdee S, Fukao T, Hanson MS, Fernandez LA, Odorico J.

J Biol Chem. 2011 May 27;286(21):18383-96. doi: 10.1074/jbc.M111.241182. Epub 2011 Mar 22.

9.

Regulation of cAMP by phosphodiesterases in erythrocytes.

Adderley SP, Sprague RS, Stephenson AH, Hanson MS.

Pharmacol Rep. 2010 May-Jun;62(3):475-82. Review.

10.

Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase.

Hanson MS, Stephenson AH, Bowles EA, Sprague RS.

Exp Biol Med (Maywood). 2010 Feb;235(2):256-62. doi: 10.1258/ebm.2009.009206.

11.

A simplified approach to human islet quality assessment.

Hanson MS, Park EE, Sears ML, Greenwood KK, Danobeitia JS, Hullett DA, Fernandez LA.

Transplantation. 2010 May 27;89(10):1178-88. doi: 10.1097/TP.0b013e3181d54bce.

12.

Insulin inhibits low oxygen-induced ATP release from human erythrocytes: implication for vascular control.

Hanson MS, Ellsworth ML, Achilleus D, Stephenson AH, Bowles EA, Sridharan M, Adderley S, Sprague RS.

Microcirculation. 2009 Jul;16(5):424-33. doi: 10.1080/10739680902855218. Epub 2009 Apr 29.

13.

IL-1beta receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis.

Schwarznau A, Hanson MS, Sperger JM, Schram BR, Danobeitia JS, Greenwood KK, Vijayan A, Fernandez LA.

J Cell Physiol. 2009 Aug;220(2):341-7. doi: 10.1002/jcp.21770.

14.

Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension.

Sprague RS, Hanson MS, Achilleus D, Bowles EA, Stephenson AH, Sridharan M, Adderley S, Procknow J, Ellsworth ML.

Pharmacol Rep. 2009 Jan-Feb;61(1):183-90.

15.

Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.

Adderley SP, Dufaux EA, Sridharan M, Bowles EA, Hanson MS, Stephenson AH, Ellsworth ML, Sprague RS.

Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1617-24. doi: 10.1152/ajpheart.01226.2008. Epub 2009 Feb 27.

16.

Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.

Hanson MS, Stephenson AH, Bowles EA, Sridharan M, Adderley S, Sprague RS.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H786-93. doi: 10.1152/ajpheart.00349.2008. Epub 2008 Jun 27.

17.

Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.

Sprague RS, Bowles EA, Hanson MS, DuFaux EA, Sridharan M, Adderley S, Ellsworth ML, Stephenson AH.

Microcirculation. 2008 Jul;15(5):461-71. doi: 10.1080/10739680701833804.

18.

Flow cytometric quantification of glucose-stimulated beta-cell metabolic flux can reveal impaired islet functional potency.

Hanson MS, Steffen A, Danobeitia JS, Ludwig B, Fernandez LA.

Cell Transplant. 2008;17(12):1337-47.

PMID:
19364071
19.

Quantification of basal and stimulated ROS levels as predictors of islet potency and function.

Armann B, Hanson MS, Hatch E, Steffen A, Fernandez LA.

Am J Transplant. 2007 Jan;7(1):38-47.

20.

Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets.

Fernandez LA, Hatch EW, Armann B, Odorico JS, Hullett DA, Sollinger HW, Hanson MS.

Transplantation. 2005 Sep 27;80(6):729-37.

PMID:
16210958
21.

Progress and controversy surrounding vaccines against Lyme disease.

Hanson MS, Edelman R.

Expert Rev Vaccines. 2003 Oct;2(5):683-703. Review.

PMID:
14711329
22.
23.

Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy.

Cassatt DR, Fazenbaker CA, Bachy CM, Hanson MS.

Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):97-102.

PMID:
11917293
24.

Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.

Ulbrandt ND, Cassatt DR, Patel NK, Roberts WC, Bachy CM, Fazenbaker CA, Hanson MS.

Infect Immun. 2001 Aug;69(8):4799-807.

25.
26.

Role of lipopolysaccharide phase variation in susceptibility of Haemophilus influenzae to bactericidal immunoglobulin M antibodies in rabbit sera.

Erwin AL, Brewah YA, Couchenour DA, Barren PR, Burke SJ, Choi GH, Lathigra R, Hanson MS, Weiser JN.

Infect Immun. 2000 May;68(5):2804-7.

27.

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.

Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S.

Vaccine. 1999 Feb 26;17(7-8):904-14.

PMID:
10067697
28.

Identification and characterization of SirA, an iron-regulated protein from Staphylococcus aureus.

Heinrichs JH, Gatlin LE, Kunsch C, Choi GH, Hanson MS.

J Bacteriol. 1999 Mar;181(5):1436-43.

29.
30.
31.

Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.

Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW, Höök M.

Infect Immun. 1998 May;66(5):2143-53.

32.

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD.

J Exp Med. 1996 Nov 1;184(5):2049-53.

33.

Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.

Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH.

J Immunol. 1996 Aug 1;157(3):1279-87.

PMID:
8757636
34.

Chronic inflammation caused by lymphotoxin is lymphoid neogenesis.

Kratz A, Campos-Neto A, Hanson MS, Ruddle NH.

J Exp Med. 1996 Apr 1;183(4):1461-72.

35.

Emv30null NOD-scid mice. An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells.

Serreze DV, Leiter EH, Hanson MS, Christianson SW, Shultz LD, Hesselton RM, Greiner DL.

Diabetes. 1995 Dec;44(12):1392-8.

PMID:
7589844
36.

Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery.

Hanson MS, Lapcevich CV, Haun SL.

Ann N Y Acad Sci. 1995 May 31;754:214-21.

PMID:
7625654
37.

Lymphotoxin: from chronic inflammation to lymphoid organs.

Sacca R, Kratz A, Campos-Neto A, Hanson MS, Ruddle NH.

J Inflamm. 1995-1996;47(1-2):81-4. Review. No abstract available.

PMID:
8913933
38.

Efficacy and safety of live recombinant BCG vaccines.

Hanson MS, Bansal GP, Langermann S, Stover CK, Orme I.

Dev Biol Stand. 1995;84:229-36. Review.

PMID:
7796958
39.

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, Briles DE, Stover CK.

J Exp Med. 1994 Dec 1;180(6):2277-86.

40.

Protective immunity elicited by rBCG vaccines.

Stover CK, Bansal GP, Langerman S, Hanson MS.

Dev Biol Stand. 1994;82:163-70. Review.

PMID:
7958471
41.

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG.

J Exp Med. 1993 Jul 1;178(1):197-209.

43.

Identification of a genetic locus of Haemophilus influenzae type b necessary for the binding and utilization of heme bound to human hemopexin.

Hanson MS, Pelzel SE, Latimer J, Muller-Eberhard U, Hansen EJ.

Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1973-7.

44.

Use of recombinant BCG as a vaccine delivery vehicle.

Stover CK, de la Cruz VF, Bansal GP, Hanson MS, Fuerst TR, Jacobs WR Jr, Bloom BR.

Adv Exp Med Biol. 1992;327:175-82. Review. No abstract available.

PMID:
1295338
45.

State also pays for Depo-Provera.

Hanson MS.

Minn Med. 1991 Jun;74(6):7-8.

PMID:
1830920
46.

Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B.

Cope LD, Yogev R, Mertsola J, Latimer JL, Hanson MS, McCracken GH Jr, Hansen EJ.

Mol Microbiol. 1991 May;5(5):1113-24.

PMID:
1956289
48.

Specific detection of Haemophilus influenzae type b lipooligosaccharide by a polymyxin B monoclonal antibody assay.

Mertsola J, Ramilo O, Sáez-Llorens X, Hanson MS, McCracken GH Jr, Hansen EJ.

J Immunol Methods. 1989 Sep 1;122(2):219-26.

PMID:
2551967
49.
50.

Supplemental Content

Loading ...
Support Center